Sign in

CIK 0001674930

  • Accelerated filer

Fulgent Genetics, Inc.

Sign in to watch
Ticker
FLGT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812621304
Phone
+1 626-350-0537
Business address
4399 SANTA ANITA AVE, EL MONTE, CA, 91731
Former names
Fulgent Diagnostics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$117,132
in 4 filings

Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-09-30 BOLGER JOHN C Director Grant or award · Issuer Stock Option (Right to Buy) +2,631 2,631
2016-09-30 Gao Hanlin Chief Scientific Officer Returned to the company −13,434,211 0
2016-09-30 Gao Hanlin Chief Scientific Officer Grant or award +1,767,659 1,767,659
2016-09-30 Xi Long USA, Inc. 10% owner Other acquisition +2,025,623 2,025,623
2016-09-30 Xi Long USA, Inc. 10% owner Other disposition · Predecessor Class D-2 Preferred Units −15,394,737 0
2016-09-30 Yen Yun Director Returned to the company −4,000,000 0
2016-09-30 Yen Yun Director Grant or award +526,315 526,315
2016-09-30 KIM PAUL CFO and Treasurer Returned to the company −500,000 0
2016-09-30 KIM PAUL CFO and Treasurer Returned to the company −2,500,000 0
2016-09-30 KIM PAUL CFO and Treasurer Grant or award +394,736 394,736
2016-09-30 Hsieh Ming President and CEO Grant or award +5,444,944 5,444,944
2016-09-30 Hsieh Ming President and CEO Grant or award +1,315,789 1,315,789
2016-09-30 Hsieh Ming President and CEO Purchase +1,000,000 $9.00 $9.0M 6,444,944
2016-09-30 Hsieh Ming President and CEO Returned to the company · Predecessor Class D-1 Preferred Units −41,381,579 0
2016-09-30 Hsieh Ming President and CEO Returned to the company · Predecessor Class D-1 Preferred Units −10,000,000 0
2016-08-12 KIM PAUL CFO and Treasurer Grant or award +500,000 500,000
2016-06-22 BOLGER JOHN C Director Grant or award · Predecessor Unit Option (Right to Buy) +20,000 20,000
2016-05-13 Gao Hanlin Chief Scientific Officer Sale −2,565,789 $1.17 $3.0M 13,434,211
2016-05-13 Hsieh Ming President and CEO Grant or award +1 $0.00 $0 1
2016-05-13 Hsieh Ming President and CEO Sale · Predecessor Class D-1 Preferred Units −4,618,421 $1.17 $5.4M 41,381,579

Page 30 of 31 · 601 trades